Skip to main content
QNTM
NASDAQ Life Sciences

Quantum Biopharma Secures Cash Runway to 2028, Eliminating Going Concern Risk

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$3.79
Mkt Cap
$15.771M
52W Low
$2.07
52W High
$38.25
52W Position info
83% above low
Off High info
90% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

QNTM sits 83% above its 52-week low of $2.07.

Summary

Quantum Biopharma reported its 2025 audited year-end financial results, confirming a 'No Going Concern' status and projecting a cash runway through January 2028, supported by $11.3 million USD in cash and digital assets. This positive financial update directly addresses and mitigates potential concerns raised by the recent 20-F filing, which highlighted a substantial net loss and significant cash burn for 2025. For a small biotech, eliminating the 'going concern' risk and extending the cash runway by several years is a highly material positive development, significantly de-risking the investment thesis. The company also demonstrated improved financial management, including a 50% reduction in payables and a 5% decrease in operating expenses. Investors will now monitor the company's progress on its Lucid-MS Phase 2 clinical trials and the commercialization efforts for unbuzzd, as these will be key to future revenue generation and sustained profitability.

At the time of this announcement, QNTM was trading at $3.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.8M. The 52-week trading range was $2.07 to $38.25. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

QNTM - Latest Insights

QNTM
Nov 12, 2026, 4:06 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.78
Real-time Price: $1.60 info
Change: -$0.180 (-10%) info
Market Cap: $13.021M info
QNTM
Nov 12, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $1.60 info
Change: -$0.400 (-20%) info
Market Cap: $13.021M info
QNTM
Oct 08, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $1.60 info
Change: -$1.49 (-48%) info
Market Cap: $13.021M info
QNTM
Oct 06, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.27
Real-time Price: $1.60 info
Change: -$1.67 (-51%) info
Market Cap: $13.021M info
QNTM
Sep 01, 2026, 8:28 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.02
Real-time Price: $1.60 info
Change: -$1.42 (-47%) info
Market Cap: $13.021M info